The effective translation of insights gained from biomedical research into improved human health is a global priority. To this end, Elsevier has looked to the leadership of its two leading brands, Cell and The Lancet, to guide the launch of a new comprehensive, online-only open access Elsevier journal, EBioMedicine, focused on forming a community that spans this interface and creates a valuable opportunity for dialogue and collaboration between their respective audiences.
-
Publisher
-
Elsevier
-
Website
-
http://www.ebiomedicine.com/
Some content fromWikipedia, licensed underCC BY-SA